Karen Firestone's Insider Trades & SAST Disclosures
Karen Firestone's most recent trade in Amylyx Pharmaceuticals Inc was a trade of 50,000 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on Sept. 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Karen Firestone.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amylyx Pharmaceuticals Inc | Karen Firestone | Director | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 05 Sep 2024 | 50,000 | 55,000 | - | 2.1 | 106,590 | Common Stock |
| Amylyx Pharmaceuticals Inc | Karen Firestone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Amylyx Pharmaceuticals Inc | Karen Firestone | Director | Purchase of securities on an exchange or from another person at price $ 14.97 per share. | 15 Dec 2023 | 4,000 | 5,000 | - | 15.0 | 59,880 | Common Stock |
| Amylyx Pharmaceuticals Inc | Karen Firestone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 3,908 | 3,908 | - | - | Stock Option (right to buy) | |
| Amylyx Pharmaceuticals Inc | Karen Firestone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 27,403 | 27,403 | - | - | Stock Option (Right to Buy) | |
| Amylyx Pharmaceuticals Inc | Karen Firestone | Director | Purchase of securities on an exchange or from another person at price $ 31.99 per share. | 16 Mar 2023 | 1,000 | 1,000 | - | 32.0 | 31,990 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges